Teva Ratiopharm Austria

Last updated: 13.02.2014

Address: Albert-Schweitzer-Gasse 3 1140 Vienna

Tel: +43 1 97 007


Company description

In 1958, Ludwig Merckle GmbH in Vienna was founded as the first foreign branch of the German Merckle Arzneimittel GmbH. This was renamed ratiopharm Arzneimittel Vertriebs-GmbH 40 years later. In the years that followed, the company specialized in the marketing and sales of generic medication – copies of original pharmaceuticals already available made with identical active substances – as well as over-the-counter medicinal products (OTC medicines). Biotechnologically produced medicines (biologicals) for the supportive therapy of cancer patients have also been in the range since 2009. In 2011 the portfolio was supplemented by Copaxone® Austria’s leading treatment for multiple sclerosis as well as a range of oncology related drugs.
The ratiopharm Group was taken over by TEVA Pharmaceutical Industries in 2010. The TEVA corporation, which specializes in the development, production and sale of generics and innovative medications, the latter for the central nervous system, oncology, pain therapy and gynaecology, is one of the 15 largest pharmaceutical companies in the world and is the market leader in the medicinal treatment of multiple sclerosis. Since the acquisition of the Cephalon Group in 2011, TEVA- ratiopharm in Austria has been offering generic brands and popular OTC products such as ratioDolor® – lately also in a joint venture with Procter & Gamble – as well as a wide range of original products, making it one of the leading pharmaceutical companies in Austria.

Products and services

TEVA-ratiopharm currently markets more than 170 products in Austria and moves around 16 Million packages per year. TEVA-ratiopharm is one of the country’s ten largest pharmaceutical companies with about ninety employees in 2012.



We use cookies to ensure that we give you the best experience on our site. For more info click here